(Updated - January 29, 2018 7:18 AM EST)

(updated to add analyst comment)Leerink Partners downgraded Abbvie (NYSE: ABBV) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change Downgrades

BMO Capital Downgrades Abbvie (ABBV) to Underperform; 'Risk/Reward Skewed to the Downside'January 29, 2018 7:34 AM Abbvie (ABBV) PT Raised to $157 at SunTrust Robinson Humphrey; Premium WarrantedJanuary 29, 2018 6:14 AM Abbvie (ABBV) PT Raised to $116 at Deutsche BankJanuary 29, 2018 6:07 AM Abbvie (ABBV) PT Raised to $120 at BarclaysJanuary 29, 2018 4:29 AM AbbVie (ABBV) Tops Q4 EPS by 4c, Raises FY18 EPS GuidanceJanuary 26, 2018 7:53 AM